Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Vey N, Bosly A, Guerci A, Feremans W, Dombret H, Dreyfus F, Bowen D, Burnett A, Dennis M, Ribrag V, Casadevall N, Legros L, Fenaux P.
Vey N, et al. Among authors: ribrag v.
J Clin Oncol. 2006 Jun 1;24(16):2465-71. doi: 10.1200/JCO.2005.03.9503. Epub 2006 May 1.
J Clin Oncol. 2006.
PMID: 16651646
Clinical Trial.